Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

34.17
-0.6800-1.95%
Post-market: 34.13-0.0379-0.11%19:57 EDT
Volume:1.79M
Turnover:61.89M
Market Cap:6.49B
PE:-9.67
High:35.60
Open:35.43
Low:34.15
Close:34.85
Loading ...

Oppenheimer Sticks to Its Hold Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
14 Jan

Strength Seen in BridgeBio Pharma (BBIO): Can Its 16.0% Jump Turn into More Strength?

Zacks
·
14 Jan

BRIEF-Bridgebio Pharma Says Got $500 Mln Upon Acoramidis U.S. Food And Drug Administration Approval

Reuters
·
14 Jan

BridgeBio Pharma Inc - Received $500 Mln Upon Acoramidis U.S. Food and Drug Administration Approval

THOMSON REUTERS
·
14 Jan

Bank of America Securities Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
14 Jan

JPMorgan ‘very encouraged’ by initial Attruby metrics presented by BridgeBio

TIPRANKS
·
14 Jan

BridgeBio Pharma in Strong Cash Position to Launch Attruby

Dow Jones
·
14 Jan

BridgeBio price target raised to $50 from $45 at Evercore ISI

TipRanks
·
24 Dec 2024

BridgeBio Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
24 Dec 2024

Piper Sandler Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
19 Dec 2024

BridgeBio Pharma Price Target Maintained With a $49.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Dec 2024

BridgeBio's Acoramidis Recommended by EU Panel for Transthyretin Amyloid Cardiomyopathy

MT Newswires Live
·
13 Dec 2024

BRIEF-EMA'S CHMP Says No Need for Separate Mounjaro Indication for OSA in Obese Adults

Reuters
·
13 Dec 2024

Ema's Chmp: Adopted Positive Opinion for Beyonttra (Acoramidis)

THOMSON REUTERS
·
13 Dec 2024

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Disc Medicine (IRON) and BridgeBio Pharma (BBIO)

TIPRANKS
·
09 Dec 2024

Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More

Zacks
·
30 Nov 2024

BridgeBio Stock Up on FDA Approval of Cardiovascular Drug

Zacks
·
26 Nov 2024

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

Zacks
·
26 Nov 2024

Sector Update: Health Care Stocks Rise in Monday Afternoon Trading

MT Newswires Live
·
26 Nov 2024

Update: BridgeBio Pharma Shares Surge After Obtaining FDA Approval for Attruby

MT Newswires Live
·
26 Nov 2024